Researchers developed series2signal, a novel, state-of-the-art prediction model that used wearable data from pregnant women to predict gestational age as a proxy for the progression of pregnancy and the likelihood of poor pregnancy outcomes, especially preterm birth, based on wearable-detected changes in maternal sleep quality and physical activity levels.
Novo Nordisk plans for life after Wegovy, setting up roots in Boston to try and find its future
LEXINGTON, Mass. — The world’s second-most valuable pharma company is on the hunt for its next big breakthrough, and it thinks the sequel to Ozempic
February 29, 2024